Qualification：

Patent Attorney since 2003

Technical Field：

Organic Chemistry、Inorganic Chemistry、Agricultural Science & Technology 、Food science and technology、Medicine & Pharmaceuticals、Life Sciences/& Healthcare

Languages：

Chinese、English

Education and Training：

Master of Science in Developmental Biology, the Institute of Developmental Biology, Chinese Academy of Sciences, 1997

Trained in a German law firm in 2003

Trained in a US law firm in 2010

Study in University of New Hampshire School of Law (Franklin Pierce Law Center) in 2014

Professional Experience：

Teacher at the Capital University of Medical Sciences, from 1997 to 2001

Joined CCPIT Patent and Trademark Law Office in 2001

Group Leader of Biotech Group in CCPIT Patent and Trademark Law Office from 2008 to 2013

Deputy Director of Chemical Department of CCPIT Patent and Trademark Law Office since 2013

Practice Area：

Drafting Patent Application Documents、Patent prosecution (including domestic patent application, PCT application and foreign patent application、Patent Reexamination、Patent Invalidation、Patent validity Litigation、Patent Infringement Litigation、Legal Opinion on Patent Infringement、Administrative Protection of Patent Right、Licensing/Assignment of Patent、Patent Search、Patent portfolio management、FTO Opinion、Third-party Observation/Public Opinion、Patent Landscape、Patent mining、Patent strategy design、Intellectual property training、Novelty search

IP Litigation and dispute resolution including negotiation, mediation and arbitration、Infringement risks analysis、IP infringement analysis、IP infringement investigation、IP due diligence investigation、IP contract drafting and reviewing、Consulting on IP strategy

Affiliation：

Chinese Group of AIPPI

LES China

All China Patent Agents Association

Publication and Presentation：

Author: The Dilemma and Solutions of Intellectual Property Protection for Pharmaceutical Innovation in China, Zhichanli, 2020-06-28, http://ipr.zhichanli.com/article/9209.html。
Co-author: Patenting Regenerative Medicine in China, The Patent Lawyer Magazine, 7/8 and 9/10, 2018
Co-author: Patenting Pharmaceuticals in China, Pharm Pat Anal. 2016 Jul;5(4):249-59. doi: 10.4155/ppa-2016-0010. Epub 2016 Jun 24

“Developments in Pharmaceutical-Related Intellectual Property Law Legislation in China”, 2020 AIPPI World Congress Online, October 2020.
“Developments in Pharma IP and Regulatory Coordination Efforts to Stimulate Faster and Better Pharma Development in China”, AIPLA 2020 Virtual Spring Meeting, May 2020.
“Developments of Biotech/Pharma Patent Prosecution and Protection in China” , 3rd Cocreate Autumn IP Forum, Munich Germany, October 2019.
“Projecting Characteristics and Trends of Pharma Patent Invalidation in China under the New Patent Linkage System”, 3rd China Pharma IP Summit 2018, Beijing, October 2018.
“Experimental Data Requirements and Admissibility of Post-filing Experimental Data in China”, Roundtable in Life Sciences Patent Network North America，Boston, June 2018.
“Requirements for Experimental Data with Respect to Sufficient Disclosure, Inventive Step and Support Requirement in Chemical field”, BRICS IP Forum, Chengdu, March 2018.
“Understanding the Latest Developments in Pharmaceutical Patent Practice in China”, C5’s 15th International Forum on Pharmaceutical Patent Term Extensions, Munich Germany, 21st - 22nd of June 2016.
“Basics of ANDA Litigation in U.S.A.”, 2015 AIPPI China Youth IP Seminar, Beijing, July 24, 2015
“Second medical use in China and Brief introduction of AIPPI Q238”, 2014 AIPPI China IP Seminar, Beijing, August 1, 2014.
“Second medical use claims in China”, 2014 AIPPI Trilateral Meeting, Seoul, June 14, 2014.

Representative Cases：

Mr. Luo won two important patent invalidation cases on behalf of a famous multinational pharmaceutical company in 2019

Mr. Luo won two important patent invalidation cases on behalf of a famous multinational pharmaceutical company in 2018

Mr. Luo won an important patent invalidation appeal case before Beijing Intellectual Property Court on behalf of a famous university in 2018

Mr. Luo won an important compound patent invalidation case on behalf of a famous multinational pharmaceutical company in 2017

Mr. Luo won an important bio-pharmaceutical patent invalidation case on behalf of a famous multinational pharmaceutical company in 2017

Mr. Luo won an important bio-pharmaceutical patent invalidation appeal case before the Supreme People's Court in 2016

Mr. Luo won a very important bio-pharmaceutical patent reexamination appeal case before Beijing Intellectual Property Court on behalf of a famous multinational pharmaceutical company in 2016

Mr. Luo won a very important bio-pharmaceutical patent invalidation appeal case before Beijing High People's Court on behalf of a famous multinational pharmaceutical company in 2015

Mr. Luo won a very important patent invalidation case on behalf of a famous university in 2015. This case was selected as No.1 of Top 10 Patent Reexamination and Invalidation Cases by the Patent Reexamination Board in 2015

Mr. Luo won two patent invalidation cases on behalf of a multinational aquaculture company in 2011

Mr. Luo won a patent invalidation case on behalf of a multinational pharmaceutical company in 2010

Mr. Luo also participated or supervised other important and successful patent cases from 2014 to 2020. One of the cases was selected as 2014 Top 10 Innovative IP Cases by Beijing High People's Court and another case was selected as one of 2019 Top 10 Reexamination and Invalidation Cases by CNIPA